{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:38:20Z","timestamp":1794620300463,"version":"4.9.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Shanghai Municipal Science and Technology Commission","award":["19ZR1439300"],"award-info":[{"award-number":["19ZR1439300"]}]},{"name":"the Professional Training Program from Shanghai Huangpu District Health Commission","award":["2023XD04"],"award-info":[{"award-number":["2023XD04"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatohepatitis (MASH) is a severe progressive subtype of metabolic-related fatty liver disease that is defined by hepatic steatosis, hepatocyte damage, inflammation, and fibrosis. Alisol F 24-acetate (ALI), a triterpene derived from Rhizoma Alismatis, has anti-inflammatory and antioxidant properties. This study aimed to evaluate the therapeutic effects of ALI in a mouse model of MASH, RAW264.7 cells, and bone marrow-derived macrophages (BMDMs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Levels of serum biochemicals, pathological changes in the liver, pyroptosis, and expression of the Kelch-like ECH-associated protein 1(KEAP1)\/Nuclear factor E2-related factor 2 (NRF2) pathway were assessed in mice fed a methionine\u2013choline-deficient (MCD) diet with different doses of ALI. Lipopolysaccharide (LPS)-stimulated RAW264.7 cells and BMDMs were used to ascertain the potential mechanisms of ALI on macrophage polarization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We found that ALI supplementation in MCD-fed mice decreased liver pathology, lipid accumulation, inflammation, and fibrosis. Moreover, ALI could attenuate M1 polarization, promote M2 polarization, suppress pyroptosis, and reduce oxidative stress levels via the KEAP1\/NRF2 signaling pathway in tissue samples. ALI also suppressed LPS-induced RAW264.7 cells and BMDMs pyroptosis by inhibiting NLRP3 activation and reducing the level of reactive oxygen species. Molecular docking results suggested that ALI could bind with KEAP1. Overexpressing\n                      <jats:italic>Keap1<\/jats:italic>\n                      weakened the effects of ALI on pyroptosis and affirmed a role associated with KEAP1\/NRF2 pathways in macrophage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that ALI suppressed macrophage pyroptosis by targeting KEAP1\/NRF2 interactions, providing reliable data on the protective mechanism of natural antioxidants against MASH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-025-01322-8","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:24:40Z","timestamp":1768296280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Alisol F 24-acetate attenuated metabolic dysfunction-associated steatohepatitis by targeting the KEAP1\/NRF2-mediated macrophage pyroptosis"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhiwu","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keliang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianxiang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"10","key":"1322_CR1","doi-asserted-by":"publisher","first-page":"R240","DOI":"10.1530\/EC-21-0048","volume":"10","author":"K Kabarra","year":"2021","unstructured":"Kabarra K, Golabi P, Younossi ZM. Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocr Connect. 2021;10(10):R240\u20137.","journal-title":"Endocr Connect"},{"issue":"Suppl 1","key":"1322_CR2","first-page":"S1","volume":"59","author":"P Golabi","year":"2024","unstructured":"Golabi P, Owrangi S, Younossi ZM. Global perspective on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis - prevalence, clinical impact, economic implications and management strategies. Aliment Pharmacol Ther. 2024;59(Suppl 1):S1\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1322_CR3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/tgh-23-118","volume":"9","author":"X Dong","year":"2024","unstructured":"Dong X, Li JM, Lu XL, Lin XY, Hong MZ, Weng S, et al. Global burden of adult non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been steadily increasing over the past decades and is expected to persist in the future. Transl Gastroenterol Hepatol. 2024;9:33.","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"1","key":"1322_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123\u201333.","journal-title":"Hepatology"},{"issue":"4","key":"1322_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3350\/cmh.2021.0127","volume":"27","author":"HY Kim","year":"2021","unstructured":"Kim HY. Recent advances in nonalcoholic fatty liver disease metabolomics. Clin Mol Hepatol. 2021;27(4):553\u20139.","journal-title":"Clin Mol Hepatol"},{"issue":"4","key":"1322_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167271","volume":"434","author":"J Knorr","year":"2022","unstructured":"Knorr J, Wree A, Feldstein AE. Pyroptosis in steatohepatitis and liver diseases. J Mol Biol. 2022;434(4):167271.","journal-title":"J Mol Biol"},{"key":"1322_CR7","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.3389\/fimmu.2019.02852","volume":"10","author":"D vdH","year":"2019","unstructured":"vdH D, Weiskirchen R, Ruchi B. Therapeutic targeting of hepatic macrophages for the treatment of liver diseases. Front Immunol. 2019;10:2852.","journal-title":"Front Immunol"},{"issue":"3","key":"1322_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov K, Jorgensen SMD, Thomsen KL, Moller HJ, Vilstrup H, George J, et al. The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):145\u201359.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1322_CR9","first-page":"238","volume":"68","author":"S Detlef","year":"2017","unstructured":"Detlef S, Rambabu S, Xiao YuW. Determinants of fibrosis progression and regression in NASH. J Hepatol. 2017;68(2):238\u201350.","journal-title":"J Hepatol"},{"issue":"1","key":"1322_CR10","first-page":"267","volume":"51","author":"LL Debra","year":"2010","unstructured":"Debra LL, Vasanthi RS, Carol RG, Jeffrey DL. Macrophages and tissue injury: agents of defense or destruction? Annu Rev Pharmacol Toxicol. 2010;51(1):267\u201388.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, Su M, Wang Y. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"key":"1322_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.896473","author":"G Can","year":"2022","unstructured":"Can G, Qiuyu C, Chengwei T, Jinhang G. Inflammasomes and pyroptosis of liver cells in liver fibrosis. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.896473.","journal-title":"Front Immunol"},{"issue":"4","key":"1322_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jhep.2018.01.017","volume":"68","author":"IB Juliane","year":"2018","unstructured":"Juliane IB, Jesus MB. Pyroptosis: An inflammatory link between NAFLD and NASH with potential therapeutic implications. J Hepatol. 2018;68(4):643\u20135.","journal-title":"J Hepatol"},{"issue":"1","key":"1322_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","volume":"28","author":"SS Faria","year":"2021","unstructured":"Faria SS, Costantini S, de Lima VCC, de Andrade VP, Rialland M, Cedric R, et al. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer. J Biomed Sci. 2021;28(1):26.","journal-title":"J Biomed Sci"},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3389\/fimmu.2020.01149","volume":"11","author":"H Lei","year":"2020","unstructured":"Lei H, Le Y, Na C, Xinhao Z, Xuan Z, Chengbin D, et al. Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome. Front Immunol. 2020;11:1149.","journal-title":"Front Immunol"},{"issue":"5","key":"1322_CR16","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","volume":"66","author":"RM Auvro","year":"2017","unstructured":"Auvro RM, Alexander W, Avril ABR, Matthew MY, Casey DJ, Derrick MVR, et al. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. J Hepatol. 2017;66(5):1037\u201346.","journal-title":"J Hepatol"},{"issue":"5","key":"1322_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2023.13098","volume":"28","author":"Y Gao","year":"2023","unstructured":"Gao Y, Guo X, Zhou Y, Du J, Lu C, Zhang L, et al. Kynurenic acid inhibits macrophage pyroptosis by suppressing ROS production via activation of the NRF2 pathway. Mol Med Rep. 2023;28(5):1\u201311.","journal-title":"Mol Med Rep"},{"key":"1322_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102389","volume":"54","author":"S Liu","year":"2022","unstructured":"Liu S, Pi J, Zhang Q. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway. Redox Biol. 2022;54:102389.","journal-title":"Redox Biol"},{"issue":"1","key":"1322_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.taap.2009.06.009","volume":"244","author":"SK Niture","year":"2010","unstructured":"Niture SK, Kaspar JW, Shen J, Jaiswal AK. Nrf2 signaling and cell survival. Toxicol Appl Pharmacol. 2010;244(1):37\u201342.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"1322_CR20","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1159\/000485089","volume":"44","author":"L He","year":"2017","unstructured":"He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species. Cell Physiol Biochem. 2017;44(2):532\u201353.","journal-title":"Cell Physiol Biochem"},{"key":"1322_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.967193","volume":"13","author":"L Wang","year":"2022","unstructured":"Wang L, He C. Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. Front Immunol. 2022;13:967193.","journal-title":"Front Immunol"},{"issue":"4","key":"1322_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100651","volume":"5","author":"K Seedorf","year":"2023","unstructured":"Seedorf K, Weber C, Vinson C, Berger S, Vuillard LM, Kiss A, et al. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice. JHEP Rep. 2023;5(4):100651.","journal-title":"JHEP Rep"},{"key":"1322_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.117838","volume":"325","author":"S Chen","year":"2024","unstructured":"Chen S, Zeng J, Li R, Zhang Y, Tao Y, Hou Y, et al. Traditional Chinese medicine in regulating macrophage polarization in immune response of inflammatory diseases. J Ethnopharmacol. 2024;325:117838.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"1322_CR24","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3390\/biomedicines10081945","volume":"10","author":"C Bailly","year":"2022","unstructured":"Bailly C. Pharmacological properties and molecular targets of Alisol triterpenoids from Alismatis rhizoma. Biomedicines. 2022;10(8):1945.","journal-title":"Biomedicines"},{"issue":"2","key":"1322_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41419-020-2293-7","volume":"11","author":"X Jin","year":"2020","unstructured":"Jin X, Gao J, Zheng R, Yu M, Ren Y, Yan T, et al. Antagonizing circRNA_002581-miR-122-CPEB1 axis alleviates NASH through restoring PTEN-AMPK-mTOR pathway regulated autophagy. Cell Death Dis. 2020;11(2):123.","journal-title":"Cell Death Dis"},{"issue":"3-4","key":"1322_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1159\/000452560","volume":"40","author":"L Zeng","year":"2016","unstructured":"Zeng L, Tang W, Yin J, Feng L, Li Y, Yao X, et al. Alisol A 24-acetate prevents hepatic steatosis and metabolic disorders in HepG2 cells. Cell Physiol Biochem. 2016;40(3\u20134):453\u201364.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"1322_CR27","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1242\/dev.112.2.517","volume":"112","author":"L Morris","year":"1991","unstructured":"Morris L, Graham CF, Gordon S. Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4\/80. Development. 1991;112(2):517\u201326.","journal-title":"Development"},{"issue":"6","key":"1322_CR28","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jhep.2013.01.038","volume":"58","author":"J Du Plessis","year":"2013","unstructured":"Du Plessis J, Vanheel H, Janssen CE, Roos L, Slavik T, Stivaktas PI, et al. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J Hepatol. 2013;58(6):1125\u201332.","journal-title":"J Hepatol"},{"key":"1322_CR29","doi-asserted-by":"publisher","first-page":"1338125","DOI":"10.3389\/fimmu.2024.1338125","volume":"15","author":"L Ni","year":"2024","unstructured":"Ni L, Chen D, Zhao Y, Ye R, Fang P. Unveiling the flames: macrophage pyroptosis and its crucial role in liver diseases. Front Immunol. 2024;15:1338125.","journal-title":"Front Immunol"},{"key":"1322_CR30","first-page":"1","volume":"44","author":"X K","year":"2024","unstructured":"K X, Z T, Z Y, G L, W W, W M, et al. Overexpression of lncRNA HEM2M alleviates liver injury in mice with non-alcoholic fatty liver disease. Nan Fang Yi Ke Da Xue Xue Bao: J South Med Univ. 2024;44:1\u20138.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao: J South Med Univ"},{"key":"1322_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109712","volume":"115","author":"H Qiu","year":"2023","unstructured":"Qiu H, Wang W, Hu K, Liu W, Pan S, Lv Q, et al. EuHD1 protects against inflammatory injury driven by NLRP3 inflammasome. Int Immunopharmacol. 2023;115:109712.","journal-title":"Int Immunopharmacol"},{"issue":"22","key":"1322_CR32","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.1111\/jcmm.17928","volume":"27","author":"F Fangda","year":"2023","unstructured":"Fangda F, Huan L, Yu D, Yuying C, Kun T, Jin P, et al. AR\/PCC herb pair inhibits osteoblast pyroptosis to alleviate diabetes-related osteoporosis by activating Nrf2\/Keap1 pathway. J Cell Mol Med. 2023;27(22):3601\u201313.","journal-title":"J Cell Mol Med"},{"key":"1322_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26219","author":"C Stephanie","year":"2013","unstructured":"Stephanie C, Vanessa L, Femke H, Christophe VS, Christophe C, Kim O, et al. Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models. Hepatology. 2013. https:\/\/doi.org\/10.1002\/hep.26219.","journal-title":"Hepatology"},{"issue":"8","key":"1322_CR34","first-page":"1806","volume":"177","author":"W Qinyu","year":"2019","unstructured":"Qinyu W, Yangjie O, Guomin H, Cong W, Shanshan Y, Cong C, et al. Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice. Br J Pharmacol. 2019;177(8):1806\u201321.","journal-title":"Br J Pharmacol"},{"key":"1322_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.687744","volume":"12","author":"SW Wang","year":"2021","unstructured":"Wang SW, Lan T, Sheng H, Zheng F, Lei MK, Wang LX, et al. Nobiletin alleviates non-alcoholic steatohepatitis in MCD-induced mice by regulating macrophage polarization. Front Physiol. 2021;12:687744.","journal-title":"Front Physiol"},{"key":"1322_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101634","volume":"36","author":"F Xu","year":"2020","unstructured":"Xu F, Guo M, Huang W, Feng L, Zhu J, Luo K, et al. Annexin A5 regulates hepatic macrophage polarization via directly targeting PKM2 and ameliorates NASH. Redox Biol. 2020;36:101634.","journal-title":"Redox Biol"},{"key":"1322_CR37","doi-asserted-by":"publisher","first-page":"2523536","DOI":"10.1155\/2023\/2523536","volume":"2023","author":"Z Feng","year":"2023","unstructured":"Feng Z, Huang Q, Zhang X, Xu P, Li S, Ma D, et al. PPAR-gamma activation alleviates osteoarthritis through both the Nrf2\/NLRP3 and PGC-1alpha\/Deltapsi (m) pathways by inhibiting pyroptosis. PPAR Res. 2023;2023:2523536.","journal-title":"PPAR Res"},{"issue":"9","key":"1322_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23809","volume":"38","author":"S Zhang","year":"2024","unstructured":"Zhang S, Zheng S, Li Y, Yang J, Mao X, Liu T, et al. Protective effects of syringic acid in nonalcoholic fatty liver in rats through regulation of Nrf2\/HO-1 signaling pathway. J Biochem Mol Toxicol. 2024;38(9):e23809.","journal-title":"J Biochem Mol Toxicol"},{"key":"1322_CR39","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.freeradbiomed.2024.12.036","volume":"227","author":"F Chi","year":"2025","unstructured":"Chi F, Cheng C, Liu K, Sun T, Zhang M, Hou Y, et al. Baicalein disrupts the KEAP1-NRF2 interaction to alleviate oxidative stress injury by inhibiting M1 macrophage polarization. Free Radic Biol Med. 2025;227:557\u201369.","journal-title":"Free Radic Biol Med"},{"key":"1322_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.151291","volume":"747","author":"L Zhang","year":"2025","unstructured":"Zhang L, Du FH, Kun KX, Yan Y. Abscisic acid improves non-alcoholic fatty liver disease in mice through the AMPK\/NRF2\/KEAP1 signaling axis. Biochem Biophys Res Commun. 2025;747:151291.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-025-01322-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-025-01322-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:18:15Z","timestamp":1768342695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-025-01322-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1186\/s13020-025-01322-8","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Animal Experimental Ethics Committee of Shanghai Second People\u2019s Hospital (IACUC number: 2025-0027) and followed the guidelines of the Basel Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors give their consent for the publication of identifiable details, which can include data and content to be published in the above Journal and Article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}